Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,011 | 2,164 | 6,258 | 10,205 | 13,778 |
| TOTAL | $1,258 | $2,719 | $6,491 | $10,588 | $14,536 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 3 | 23 | 160 |
| Intangibles | 509 | 666 | 823 | 980 | 0 |
| TOTAL | $509 | $666 | $826 | $1,003 | $160 |
| Total Assets | $1,767 | $3,385 | $7,317 | $11,591 | $14,696 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 254 | 124 | 88 | 233 | 77 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 13 |
| TOTAL | $261 | $282 | $100 | $294 | $119 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,000 | 0 | 193 | 473 | 0 |
| TOTAL | $1,000 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,261 | $282 | $100 | $294 | $119 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 41 | 41 | 41 | 41 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -188,956 | -186,185 | -182,018 | -178,097 | -174,517 |
| Other shareholders' equity | 0 | 0 | 0 | 193 | 0 |
| TOTAL | $506 | $3,103 | $7,217 | $11,297 | $14,577 |
| Total Liabilities And Equity | $1,767 | $3,385 | $7,317 | $11,591 | $14,696 |